Indian Journal of Palliative Care
Open access journal 
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size Users online: 1080  
     Home | About | Feedback | Login 
  Current Issue Back Issues Editorial Board Authors and Reviewers How to Subscribe Advertise with us Contact Us Analgesic Prescription  
  Navigate Here 
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (386 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

  In this Article
 »  Abstract
 » Introduction
 »  Epidemiology of ...
 »  Unique Diagnosti...
 »  Specific Palliat...
 »  Barriers for Pro...
 »  Solutions for th...
 » Conclusion
 »  References
 »  Article Tables

 Article Access Statistics
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal


Table of Contents 
Year : 2020  |  Volume : 26  |  Issue : 5  |  Page : 130-141

Palliative care delivery in cancer patients in the era of Covid-19 outbreak: Unique needs, barriers, and tools for solutions

Department of Onco-Anaesthesia and Palliative Medicine, Dr. Bhimrao Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Date of Submission30-May-2020
Date of Acceptance01-Jun-2020
Date of Web Publication30-Jun-2020

Correspondence Address:
Dr. Seema Mishra
Department of Onco-Anaesthesia and Palliative Medicine, Dr. Bhimrao Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/IJPC.IJPC_194_20

Rights and Permissions

 » Abstract 

World is facing a pandemic recently due to the outbreak of COVID-19 infection. Cancer has been identified as one of the major comorbidities which cause more severe disease due to COVID-19 infection. Moreover, there are several resource limitations and restrictions to avail the standard oncological health facilities due to robust measures taken for infection control. In this situation, palliative care in cancer patients deserves special attention. Their symptom management, psychological, social, cultural needs tremendously increase during the epidemic. Thus, we need to recognize the unique palliative care needs of cancer patients during pandemic and formulate the plan to maintain continuity of services. Triaging systems are essential tools for proper resource allocation during a pandemic. Therefore, we suggest triaging tools for emergency in hospital palliative care services: community-based palliative care and end of life care for cancer patients. Incorporation of newer technologies and identifying the potential resources are the other key components of the preparedness strategy.

Keywords: Cancer patients, COVID-19 pandemic, palliative care

How to cite this article:
Mishra S, Biswas S, Bhatnagar S. Palliative care delivery in cancer patients in the era of Covid-19 outbreak: Unique needs, barriers, and tools for solutions. Indian J Palliat Care 2020;26, Suppl S1:130-41

How to cite this URL:
Mishra S, Biswas S, Bhatnagar S. Palliative care delivery in cancer patients in the era of Covid-19 outbreak: Unique needs, barriers, and tools for solutions. Indian J Palliat Care [serial online] 2020 [cited 2020 Jul 14];26, Suppl S1:130-41. Available from:

 » Introduction Top

Cancer is one of the major causes of disease burden all over the world. As stated by the World Health Organization (WHO) in 2018, it is the second leading cause of death across the world.[1] Cancer patients are at high risk of severe respiratory infections due to their immunosuppression, age, and comorbidities.[2] There is also a high rate of mortality among them due to pneumonia of viral origin.[3] Thus, care of advanced cancer patients needs special attention amidst the pandemic of a viral respiratory illness.

Novel coronavirus (COVID-19) disease has been declared as global pandemic on March 11, 2020 by the WHO.[4] It is caused by severe acute respiratory syndrome–coronavirus (SARS-COV-2), a beta-coronavirus, belonging to the family of coronaviridae.[5] World is now witnessing the third emergence of SARS, previous two episodes being in the year of 2003 and 2012.[6],[7],[8] The first case of novel coronavirus was reported in December 2019 at Wuhan, China. Since then, a total 1,914,916 numbers of confirmed cases and 123,010 numbers of deaths have been reported across >200 countries, territories, or areas by April 15, 2020.[9]

The level of contagiousness of this infection is denoted by the basic reproductive number (R0).[10] It is defined as numbers of secondary cases stemming from a primary case in a susceptible population. The basic reproductive number (R0) of the novel coronavirus has been found to be highly variable in different countries[10],[11] and can be as high as up to 5.7.[12] Owing to the high level of contagiousness, an aggressive contact tracing, isolation, and social distancing are the major strategies for containment of the infection.[12] Many countries have opted for a lockdown mode to ensure an effective social distancing.

This particular situation has caused tremendous difficulty to support different health-care services including palliative care for cancer patients.[13] Thus, a palliative care team needs to have a contingency and crisis management plan to maintain the continuity of services to a huge number of cancer patients during the pandemic. In this review article, we discuss the specific palliative care needs in cancer patients amidst the COVID-19 pandemic, barriers to meet those needs, and potential solutions of them.

 » Epidemiology of Cancer Patients and Novel Coronavirus Infection Top

A few studies from China and Italy have shown the epidemiology of COVID-19 among cancer patients.[14],[15],[16] A study by Liang et al.[14] has been published in Lancet oncology, which shows a nationwide analysis of patients with novel coronavirus in China with special focus on cancer patients. It showed that 18 patients (1%) out of the total 1590 cases of novel coronavirus had a history of cancer as compared to the general population (0.29%). Lung cancer (28%) was found to be the most common type of cancers among them. They also found a higher incidence of complications among the cancer patients (39% vs. 8%) (Complication defined as intensive care unit (ICU) admission for patients who require intubation and mechanical ventilation or death).[14] Age was found to be a major indicator of severity in the cohorts of cancer patients (mean, 63.1 years vs. 48.7 years). They also had a higher incidence of smoking (22% vs. 7%) and severe baseline computed tomography (CT) scan manifestations (94% vs. 71%). Four (25%) out of 16 patients (2 out of 18 patients had unknown treatment status) received chemotherapy or surgery within the last 1 month and the rest of them were cancer survivors after primary surgery.

Another retrospective analysis[15] from China revealed data of 28 cancer patients infected with COVID-19. These patients had fever (82.1%), dry cough (81%), and dyspnea (50%) as presenting symptoms. Laboratory investigations revealed lymphopenia (82.1%), raised C-reactive protein (82.1%), anemia (75.0%), and hypoproteinemia (n = 25, 89.3%).

Both the studies[14],[15] have a very small sample size with much heterogeneity regarding disease duration, course, origin, treatment history, and need to be extrapolated on larger cancer populations with caution.

The initial data from Italy show that around 20% of the patients who died of coronavirus infection had a history of cancer in the last 5 years.[16] However, this study only considers patients who died due to COVID-19 infections. Thus, these findings also cannot be interpreted for the overall population.

Hematological malignancies are another group of cancer, which is at high risk of COVID-19 patients. Before the emergence of SARS-COV-2, it was shown that 30% of patients with history of hematopoietic stem cell transplantation had progression from upper to lower respiratory tract infection due to seasonal less pathogenic coronavirus.[17]

Thus, patients with lung cancer and hematological cancers, receiving chemotherapy or surgery, and old age with multiple comorbidities are expected to have a greater chance of having COVID-19 infection. However, further good quality data with specific analysis of subgroup patients are warranted to establish the epidemiological links and to assess the impact of the pandemic on cancer patients precisely.

 » Unique Diagnostic Challenge of Novel Coronavirus Infection in Cancer Patients Top

Patients with novel coronavirus infection commonly present with symptoms such as fever, cough, and shortness of breath. In severe cases, they may present with acute respiratory distress syndrome (ARDS) and septic shock too.[18] As per the WHO,[19] cases are being defined as suspected, probable, or confirmed. People who have developed signs of acute respiratory tract infections with a travel history within 14 days or belong to a location with community transmission are considered as suspected cases. A laboratory evidence of COVID-19 infection irrespective of presence of symptoms is to be declared as confirmed cases.[19]

The patients with cancers, specially primary or metastatic lung cancers, also do often present with similar symptoms, e.g., cough, fatigue, dyspnea, and chest pain.[20] In addition, the similar symptoms can also be caused by the lung injury following radiation[21] or during febrile neutropenia following chemotherapy.[22] Thus, in this era of pandemic, it is extremely challenging for physicians to differentiate and diagnose COVID-19 infection in these patients. Therefore, cancer patients need more careful and strategic screening for COVID-19 infection.

According to the WHO definitions,[19] an epidemiological link within a 14-day period is required along with clinical symptoms and laboratory evidence. This is a major reference point in differentiating the diagnosis in lung cancer patients. History regarding previous treatments can also serve as a clue. Additional imaging modalities, e.g., CT scan, can also help to differentiate between the diagnoses. Liang et al.[14] reported that cancer patients with COVID-19 infection presented with more severe CT image changes (94% vs. 71%). Thus, for acute onset dyspnea in cancer patients, the epidemiological and contact history should be checked first, followed by combining a treatment history and laboratory findings. In patients who have received a recent chemotherapy, neutropenic sepsis should also be ruled out simultaneously, as it is a medical emergency.[23]

 » Specific Palliative Care Needs of Cancer Patients and Barriers to Meet Them during Pandemic Top

Palliative care encompasses a holistic care which addresses several needs of a patient, including their psychological and social one. During the pandemic, the process of isolation, quarantine, and social distancing affects these needs to a great extent. Depression (15% major, 20% minor) and anxiety (10%) are common findings in cancer patients.[24] In the era of pandemic of an infectious disease, fear of deprivation from standard treatment, fear of getting the infection, fear of social isolation and stigmatization, and news of deaths, may augment these psychological issues.[25],[26],[27],[28] Moreover, rapid surge of cases and high fatality rate causes greater consumption of medical resources for infected patients including drugs, equipment, and specialist palliative care physicians.[29],[30],[31],[32] Thus, with limited resources, we need to identify the specific needs of cancer patients and barriers to meet them in the pandemic era, as early as possible to maintain the continuity of care. The different palliative care needs of cancer patients, caregivers, and health-care workers during COVID-19 are summarized in [Table 1].
Table 1: Palliative care needs for cancer patients during COVID-19 pandemic

Click here to view

 » Barriers for Providing Palliative Care in Cancer Patients Top

The barriers of providing a holistic care to the cancer patients during a pandemic encompasses three levels: patient, caregiver, and health system itself [Table 2].
Table 2: Barriers to provide palliative care services to cancer patients during pandemic

Click here to view


Weighing the balance between infection prevention and decreasing the need of social isolation is a real challenge for cancer patients. Social distancing should be practiced in place of social isolation in these patients.[33] As lack of social support is anticipated during the period of lockdown, there should be timely discussion regarding planning for help among the peer group. Increasing social support can also improve the chance of access to systemic therapies and in hospital services.[34] The patient and family members should be thoroughly educated about infection control strategies to decrease the risk of infection. Telemedicine is a viable option for managing their symptoms and psychological issues without increasing further risk of infection.[35]


During the pandemic, family-centered care is becoming the popular model for patient care.[36] Family members of patients also face three types of barriers while caring their patients during pandemic.[37] These are social distancing and related health hazards,[38] a lack of social support system, and economic pressure due to loss of jobs. To minimize the effects of social distancing, some relaxation for physical presence of family members at bedside with adequate precautions can be allowed to a pediatric patient or end of life care (EOLC) patients.[36] Caregivers should be involved in early discussion of care of goals with the patients and advanced care planning.[36],[39] Difficulty in communications with caregivers can be overcome by compassionate conversations and reassuring them.[39],[40] Telemedicine capacity should be strengthened with active participation of the family members along with patients and physicians for shared decision-making and care.[41],[42] One needs to consider the fact that all caregivers may not be well equipped for videoconferencing and thus a simple teleconsultation via phone may be the only option for them.[36] During pandemic, the caregivers often face the grief of losing loved ones. The limited access and resources hampers appropriate bereavement services to them. Proper communication, early recognition of stressors during EOLC, and developing personalized care plans for them can be essentially helpful for them.[43]

Health-care system

The health-care system has also undergone a lot of modifications in their practices due to the strict impositions of lockdown. The limitations on movement, sealing of borders caused lack of availability of essential drugs, especially opioids.[44] Telemedicine services with video calls for the prescription of opioids can be a solution to this.[45] The demand of acute palliative services for nonmalignant patients during pandemic rises sharply, diverting the resources for them.[46] In addition to this, health-care workers often need to self-isolate them following an exposure, which decreases the manpower to work.[47] To manage the huge number of referrals, hospitals, hospices, and community-based care organizations should be well trained and well equipped.[31],[48] The ethical dilemma for allocating resources is another valid concern.[49],[50],[51] Effective triaging systems should be established for careful rationing of palliative care resources for patients. It is important to take care of the service providers too. Long working hours and risk of accidental exposure may cause more stress and burnout symptoms among cancer service providers.[52] Thus, their well-being should be considered and integrated during making a policy for hospital preparedness.[53]

 » Solutions for the Needs Top

To maintain the quality palliative care services for cancer patients, we need to be prepared to meet the increased needs. Resource limitation and personnel mobility restrictions are major barriers for that purpose. Hence, we need to formulate a “pandemic plan” to overcome these barriers. Developing a triaging system to allocate the resources effectively, protocol-based symptoms management, and incorporation of telemedicine is the key components of such plan. The objectives and principles of such a “pandemic plan” are minimizing the risk of infection with providing quality of life as much as possible.

Preparedness of palliative care: Preparing a “Pandemic Plan”

In view of oversaturation of the health-care system and limited resources, formulation of a pandemic plan to maintain continuity of palliative care services and meet the increased needs of cancer patients is of utmost importance. The “4S” model for pandemic preparedness was proposed by Downar et al.[54] during the influenza epidemic in 2010. There is an expected surge of requirement of acute palliative care services and resources for noncancer patients during a pandemic.[46] To maintain the equity of services to the cancer patients, we need to categorically prepare our palliative care unit. The preparedness should focus on the following domains of palliative care resources:


Build up the reserve for essential medications and equipment for managing common symptoms and palliative emergencies for cancer patients, e.g., opioids, haloperidol, midazolam, paracetamol, steroids, oxygen, infusion pumps, subcutaneous cannula, etc., Adequate supply of personal protective equipment (PPE) should be arranged for the health-care workers.


Due to deployment of staff in the frontline, we need to anticipate a decrease in manpower and reorganize the unit accordingly. Specialist palliative care services may not always be available for the cancer patients during a pandemic. Hence, all potential health-care workers who can be trained for palliative care services, including oncologists, nursing staffs, community health workers should be identified at earliest and trained for symptoms assessment, triaging and advanced care planning. Allied health-care workers, e.g., spiritual or social workers should also be identified to provide psychosocial support for the cancer patients.


We need to accommodate a large number of dying patients. This mandates creation of more spaces and wards with facilities for EOLC. The hospices and community health-care facilities should be used with its maximum capacity and potential. Isolation wards with access to palliative care services should be established in all cancer care hospitals to accommodate infected cancer patients. In addition to these, we need to reorganize our office spaces to maintain social distancing norms.


Triaging is the best tool for allocation of resources effectively during a pandemic. There should be a triaging system for in hospital palliative care services, home visits and community-based palliative care, and initiation of EOLC. An easy protocol for symptoms management should be developed for cancer patients. This will ease the job of training of physicians and other health care workers for providing community-based services. Patients should be educated with flyers mentioning DO's and Don'ts for infection control. Building up a system of telemedicine is the need of the hour. It can be used for symptoms management, psychological support, educating family patients, and health-care workers. Last but not the least, a flexible appropriate system for death rituals and bereavement support should be established.

Skills of communication

Communication with a dying patient is a skill indeed. During a pandemic, difficult access to the patients, isolation, and disconnectedness from family make it more challenging. Educating the staff for skills of communication at the end of life should be a priority. Acknowledging, listening with compassion, and repeated reassurance to patients and relatives are the key of such communication skills. New technological supports, e.g., use of smartphones for video calling, are of great adjuncts to develop the communication system.


Health-care workers undergo tremendous physical and mental stress during a pandemic. The disrupted work schedule, separation from family, seeing patients dying daily, and fear of infection make them really vulnerable. Peer support groups should be established to take care of each other. They should be connected with family over phones. Team leaders should learn how to help the members in taking morally challenging decisions and keep them motivated.

Considerations while developing standardized protocols for palliative care and symptoms management

Due to limited resources, several restrictions on movement and social distancing, managing all cancer patients' needs by specialist palliative care teams may be out of our capacity. Every specialist palliative care centers need to coordinate and involve other primary and secondary level health-care systems of their regions for providing a quality palliative care for all cancer patients when they are in need. To enable this, it is important to develop an easy standardized protocol for common symptoms management of cancer patients.[55] It should also include management of common symptoms due to COVID-19 infection, e.g., fever, breathlessness, cough, respiratory secretions, and delirium [Table 3].
Table 3: Protocol for common symptoms management

Click here to view

There are some special considerations and controversies for cancer patients during symptoms management amidst COVID-19 pandemic. Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most common drugs for management of cancer pain, as proposed by the WHO.[56] However, there are some controversies regarding its use in COVID-19 infection. Use of indomethacin increases the express of angiotensin converting enzymes-2 and thus can facilitate COVID-19 infection.[57] In contrast to this, in a study evaluating indomethacin in gout and rheumatoid arthritis patients, it was found to have antiviral activity bothin vivo andin vitro against human novel coronavirus.[58]

Similar controversy exists for the use of steroids in these infected patients. In most of the trials, it showed a positive impact due to their immunomodulatory effect.[59],[60] But, the matter of concern is the effect of steroids on viral replication and associated side effects. Prolonged administration of steroids in the second or 3rd week has shown increase in viral load and consequently severity of the disease including ARDS.[61],[62]

All the data available for use of steroids or NSAIDs are inadequate to draw any conclusion.[63] Thus; it is suggested to continue the medications in cancer patients for symptoms management, as maintaining quality of life is of primary importance in them.

For patients of analgesics, a dose of at least 1–3 months should be provided with proper documentation and record keeping. This will minimize unnecessary travel to the hospital and chances of getting the infection. Patients with advanced malignancy should be managed at home as much as possible. A single fractionated radiotherapy should be considered for cord compression or pain.[64],[65] For other oncological emergencies, e.g., superior vena cava syndrome, raised intracranial tension due to brain metastasis, tumor bleeding should be considered for short courses of radiotherapy.[66] Patients who require frequent hospital visits for drainage of pleural or ascitic fluids, indwelling long term catheters, e.g., PleurX should be used.[67],[68]

Blood transfusion also requires special attention in the pandemic era.[69] Cancer patients, especially the hematological cancers, often require blood transfusion. Due to social isolation, community spread of COVID-19 infection, less frequent organization of blood donation camps, there may be shortage of supply of blood at the blood banks. Thus, a restrictive blood transfusion strategy should be adopted for these patients. Iron, Folic acid, Vitamin B12 or Erythropoietin should be considered early to decrease transfusion requirements of cancer patients.[69],[70],[71]

Education of cancer patients and family for prevention of infection

COVID-19 infection is a highly contagious one. Cancers patients are considered to be at high risk of the infection. Thus, a robust infection control strategy has to be applied for them. Social distancing, restricting personnel mobility and hygiene practices are the cornerstone of this strategy. Health care workers are also at high risk of getting the infection. They should adopt to infection control measures, maintaining good hand hygiene, wear masks and other PPE as mentioned in the interim guidance by WHO.[72],[73] [Table 4] summarizes the general and special precautions to be taken by cancer patients for effective infection prevention measures. Effective implementation needs educating patients and their family members regarding these measures. Information booklets with images or videos demonstrating hand hygiene steps are effective tools for that purpose. These precautions are to be followed by all cancer patients, but, more robustly and religiously by patients with age >60 years, lung cancers, with comorbidities, history of smoking, history of chemotherapy, immunotherapy, stem cell transplantation or surgery within last 1 month.[14]
Table 4: Infection control strategy for cancer patients

Click here to view

Triaging cancer patients for in hospital palliative care and allocation of palliative care resources

In a limited resource setting in the era of pandemic, we need to redefine our hospital admission criteria for palliative care of cancer patients. The idea of this triage is to admit only those patients, who require urgent in hospital palliative intervention. This will minimize the risk of infection. The oncological patients can be categorized [Table 5] as high priority (Red), medium priority (Yellow) and low priority (green) for the need of palliative care.[74],[75] The high priority patients should receive in hospital palliative care, medium priority patients may be considered for in hospital palliative care after failure of home-based management, whereas low priority patients should be managed at home.[75]
Table 5: Triaging cancer patients for in hospital palliative care and allocation of palliative care resources

Click here to view

Triaging cancer patients for end of life care

Every patient has the right to die with dignity. EOLC practices ensure a good death for patients. For cancer patients there are several triggers for initiating EOLC plans, e.g.: advanced disease, increased age, failure of curative therapies, a poor palliative performance scale or palliative prognostication index.[76],[77]

During the pandemics, our critical care set up and ventilators are overwhelmed with patients. COVID-19 patients often do develop ARDS and thus require ventilation. In this scenario, ventilator triage is the most difficult one, as aptly described by Truog et al.[50] Sequential Organ Failure Assessment score is a key tool to predict the severity of organ damage in cancer patients and thus helpful for triaging cancer patients for ICU admission.[78] During the Influenza pandemic, Guest et al. laid out a triage plan for ICU admission and ventilation.[79] They predefined some exclusion criteria for ICU care, such as:

  • Severe impairment of cognitive functions
  • Massive trauma
  • Severe grade of heart failure
  • Severe chronic liver disease
  • Age > 85 years.

There is no data available yet about the impact of COVID 19 infection on the survival of advanced cancer patients. We suggest a potential triage system [Table 6] for EOLC in cancer patients considering the adverse effects of systemic response of COVID infection in advanced cancers. A well planned study is needed to prove the validity and outcome of such triage system. The difficulty in monitoring the patient during EOLC can be mitigated with acquiring telemetry beds.[80],[81] It may decrease the requirement of multiple visits by health workers and consumption of PPE.[80] The decision for initiation of EOLC has to be in consensus with primary oncologists treating the patient and family members. Family members can be contacted via telecommunication for this purpose if the patient is in isolation due to infection.[82] In such patients, who are in isolation and away from family, we have to be extremely compassionate to discuss and execute the EOLC.
Table 6: Triaging cancer patients for end of life care

Click here to view

Home-based palliative care of cancer patients during pandemic: Utility of a two tier triaging system

Community-based and home-based care of terminally ill cancer patients is an essential element of a quality palliative care. But, home visits of cancer patients by the palliative care team is a two edged sword. On the one hand, it is required to maintain the continuity of quality palliative care especially during a pandemic when there are several restrictions to travel and access to in hospital health services. On the other hand, it increases the chance of infection in both patient and health-care workers. To decrease this problem, a “Double Triage” model has been proposed by members of Tuscany Tumor Association in Italy in view of COVID-19 pandemic.[83] It involves two tiers.

First triage

It is a telephone-based survey. Patients are asked if the patient or any family member has any of the following symptoms in the last 48 h: fever, breathlessness or cough; whether the home belongs to an outbreak area; whether patient or family members have any history of direct contact with known or suspected COVID-19 patients. The patients who are found positive for this telescreening are referred to designated health care facilities for COVID-19 screening.

Second triage

The patients who are found negative in the first triage undergo a telephonic assessment for symptoms severity, symptoms burden and expected life expectancy with PERSONS score[84],[85] and Palliative Prognostic Score.[36] Symptoms severity was classified as uncontrolled (any item of PERSONS score has a numeric rating scale [NRS] >7); moderate (any item in PERSON score NRS 4–6) and Mild (any item PERSONS score NRS < 4). Based on these scoring systems, they created a triage system [Table 7] and planned the frequency of home visits.
Table 7: Triaging for frequency of home based palliative care of cancer patients during pandemic

Click here to view

Scope of hospices during pandemic

Hospices are the integral part of the quality palliative care system for cancer patients. Rapidly deteriorating respiratory symptoms in the terminal patients may increase hospice referral rate.[86] Potential of these hospices are tremendous in context of such an overwhelmed system. They have potential to respond rapidly and flexibly in response to the pandemic.[31],[48] They can be used as a setting for symptoms management and EOLC for infected cancer patients, who need isolation. The preparedness of hospices essentially should follow the “4S” model, which has been previously described. Protocol-based symptoms management, providing psychological support, providing bereavement services and providing assistance for telemedicine setup are some of the major potential contributions of the hospices during epidemic.[48] One major problem for the hospices are lack of funds. Most of the fundraising events for the hospices stand cancelled during the epidemic. Thus, the government needs to find out all the available hospice services and integrate their services with the health care system during pandemic preparedness.

Scope of telemedicine

Telemedicine has already been a part of routine palliative care for cancer patients in both urban and rural areas.[87] But, during the pandemic the importance has increased several folds.[88],[89] It not only assists to manage patients symptomatically, also helps for patient assessment, triaging and providing psychological and social support for both outpatients and in patients.[90],[91],[92],[93] This ensures social distancing, decreases unnecessary hospital visits and thus decreases chance of infection to both patients and health care workers. Additionally it also helps to preserve the valuable health resources.[91] Use of advanced technology and audio visual medium in smart phones or computers has made the process more dynamic. The setup needs consideration for both the patient and physician.[92] Every institute should choose one or two standard electronic platforms for telemedicine consultation, which preserves the confidentiality and safety of data.[94] Patients should be informed and trained for the telemedicine platform use during their hospital visits to avoid chaos during the actual time of emergency. One key contact person should be identified for technological liaison for the family or patient. The hospital set up for telemedicine should be a quiet and well-lit place with good internet connectivity.[92] Physicians from many specialties can join together for an integrated decision-making for both outdoor and in patients.[95],[96] Long waiting list for a telemedicine appointment, technological glitches and a variable technological literacy of patients are some of inevitable drawbacks of telemedicine.[92] Patience is the only key solution to these unavoidable problems.

 » Conclusion Top

COVID-19 pandemic has caused an impact on every sector of the health care delivery system including palliative care for cancer patients. As cancer patients are at high risk of getting infected, they need strict social distancing and infection control measures. Nationwide lockdown imposes additional difficulty to access routine oncological services, opioids, EOLC and psychological supports by palliative care physicians. Health-care workers including community-based palliative care service providers are also at risk of infection and psychological distress. We need to prepare the palliative care team to overcome these barriers with proper strategy. This includes stockpiling adequate drugs, instruments, resources; developing standard protocols for symptoms management; educating the patient and family; shift the care model to a family centric one; building up communication skills and triaging priority patients for in hospital and community-based palliative care services. Strengthening the hospice care services and building up the multidisciplinary telemedicine service capacity are some of other essential keys to maintain the continuity of holistic service to cancer patients during pandemic.


We are thankful to all the residents and faculty of Department of Oncoanaesthesia and Palliative Medicine Dr. BRAIRCH, AIIMS, Delhi, for their continuous efforts serving Palliative Care during the Covid pandemic.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

 » References Top

World Health Organization. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 1
Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med 2020;46:298-314.  Back to cited text no. 2
Kim YJ, Lee ES, Lee YS. High mortality from viral pneumonia in patients with cancer. Infect Dis (London, England) 2019;51:502-9.  Back to cited text no. 3
World Health Organization. WHO Director-General's Opening Remarks at the Media Briefing on COVID-19; 11 March, 2020. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 4
Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Gulyaeva AA, et al. Severe Acute Respiratory Syndrome-Related Coronavirus: The Species and its Viruses – A Statement of the Coronavirus Study Group. bioRxiv 2020.02.07.937862; 2020. [doi: 10.1101/2020.02.07.937862].  Back to cited text no. 5
Zhong NS, Zheng BJ, Li YM, Poon X, Chan KH, Li PH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet (London, England) 2003;362:1353-8.  Back to cited text no. 6
McIntosh K, Kapikian AZ, Turner HC, Hartley JW, Parrott RH, Chanock RM. Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol 1970;91:585-92.  Back to cited text no. 7
Alsahafi AJ, Cheng AC. The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015. Int J Infect Dis 2016;45:1-4.  Back to cited text no. 8
World Health Organization. Coronavirus Disease (COVID-2019) Situation Reports. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 9
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-207.  Back to cited text no. 10
D'Arienzo M, Coniglio A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. Biosafety Health 2020. (In press)  Back to cited text no. 11
Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis 2020;26(7):10.3201/eid2607.200282.  Back to cited text no. 12
Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nat Rev Clin Oncol 2020;17:329-31.  Back to cited text no. 13
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol 2020;21:335-7.  Back to cited text no. 14
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19 infected cancer patients; A retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894-901.  Back to cited text no. 15
Palmieri L, Andrianou X, Barbariol P, Bella A, Bellino S, Benelli E, et al. Characteristics of COVID-19 Patients Dying in Italy. Report Based on Available Data on March 20th, 2020. Available from: [Last accessed 2020 Apr 24].  Back to cited text no. 16
Eichenberger EM, Soave R, Zappetti D, Small CB, Shore T, van Besien K, et al. Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2019;54:1058-66.  Back to cited text no. 17
World Health Organization. Interim Guidance Document. Clinical Management of Severe Acute Respiratory Infections when Novel Coronavirus is Suspected: What to do and What not to do. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 18
World Health Organization. Global Surveillance for COVID-19 Caused by Human Infection with COVID-19 Virus. Interim Guidance; 20 March, 2020. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 19
Hamilton W, Peters TJ, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 2005;60:1059-65.  Back to cited text no. 20
Jain V, Berman AT. Radiation pneumonitis: Old problem, new tricks. Cancers (Basel) 2018;10:222.  Back to cited text no. 21
Patel K, West H. Febrile neutropenia. JAMA Oncol 2017;3:1751.  Back to cited text no. 22
The UK National Institute of Health and Care Excellence. COVID-19 Rapid Guideline: Delivery of Systemic Anticancer Treatments; 2020. Available from:  Back to cited text no. 23
Alexandra P, Sahil S, Nicholas H, Andrew H. Depression and anxiety in patients with cancer. BMJ 2018;361:k1415.  Back to cited text no. 24
Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. General Psychiatry 2020;33:e100213.  Back to cited text no. 25
Mazza C, Ricci E, Biondi S, Colasanti M, Ferracuti S, Napoli C, et al. A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: Immediate psychological responses and associated factors. Int J Environ Res Public Health 2020;17:3165.  Back to cited text no. 26
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020;17:1729.  Back to cited text no. 27
Pappas G, Kiriaze IJ, Giannakis P, Falagas ME. Psychosocial consequences of infectious diseases. Clin Microbiol Infect 2009;15:743-7.  Back to cited text no. 28
Arya A, Buchman S, Gagnon B, Downar J. Pandemic palliative care: Beyond ventilators and saving lives. CMAJ 2020;192:E400-4.  Back to cited text no. 29
Etkind SN, Bone AE, Lovell N, Cripps RL, Harding R, Higginson IJ, et al. The role and response of palliative care and hospice services in epidemics and pandemics: A rapid review to inform practice during the COVID-19 pandemic. J Pain Symptom Manage 2020. pii: S0885-3924 (20) 30182-2.  Back to cited text no. 30
Costantini M, Sleeman KE, Peruselli C, Higginson IJ. Response and role of palliative care during the COVID-19 pandemic: A national telephone survey of hospices in Italy. Palliat Med. 2020 (In press). doi:10.1177/0269216320920780.  Back to cited text no. 31
Strosberg MA. Allocating scarce resources in a pandemic: Ethical and public policy dimensions. Virtual Mentor 2006;8:241-4.  Back to cited text no. 32
Kelso JK, Milne GJ, Kelly H. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Public Health 2009;9:117.  Back to cited text no. 33
Moore S, Leung B, Bates A, Ho C. Social isolation: Impact on treatment and survival in patients with advanced cancer. J Clin Oncol 2018;36 34 Suppl: 156.  Back to cited text no. 34
Larson JL, Rosen AB, Wilson FA. The effect of telehealth interventions on quality of life of cancer patients: A systematic review and meta-analysis. Telemed J e Health 2018;24:6, 397-405.  Back to cited text no. 35
Hart JL, Turnbull AE, Oppenheim IM, Courtright KR. Family-centered care during the COVID-19 era. J Pain Symptom Manage 2020. (In press) 10.1016/j.jpainsymman.2020.04.017.  Back to cited text no. 36
Kent EE, Ornstein KA, Dionne-Odom JN. The family caregiving crisis meets an actual pandemic. J Pain Symptom Manage 2020. (In press). doi:10.1016/j.jpainsymman.2020.04.006.  Back to cited text no. 37
Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: A meta-analytic review. Perspect Psychol Sci 2015;10:227-37.  Back to cited text no. 38
Respecting Choices. COVID-19 Resources. Available from: [Last accessed 2020 Apr 30].  Back to cited text no. 39
Vital Talk Tips; 2020. Available from: [Last accessed 2020 Apr 30].  Back to cited text no. 40
Rahimi AS, Menear M, Robitaille H, Légaré F. Are mobile health applications useful for supporting shared decision making in diagnostic and treatment decisions? Global Health Action 2017;10 Suppl 3:1332259.  Back to cited text no. 41
Mercadante S, Adile C, Ferrera P, Giuliana F, Terruso L, Piccione T. Palliative care in the time of COVID-19. J Pain Symptom Manage 2020 (In press). doi: 10.1016/j.jpainsymman. 2020.04.025.  Back to cited text no. 42
Morris SE, Moment A, Thomas J. Caring for bereaved family members during the COVID-19 pandemic: Before and after the death of a patient. J Pain Symptom Manage 2020. (In press) doi:10.1016/j.jpainsymman.2020.05.002.  Back to cited text no. 43
Rajagopal MR, Joranson DE. India: Opioid availability – An update. J Pain Symptom Manage 2007;33:615-22.  Back to cited text no. 44
Mehta AK, Smith TJ. Palliative care for patients with cancer in the COVID-19 era. JAMA Oncol. 2020 (In press) doi:10.1001/jamaoncol.2020.1938.  Back to cited text no. 45
Fusi-Schmidhauser T, Preston NJ, Keller N, Gamondi C. Conservative management of COVID-19 patients-emergency palliative care in action. J Pain Symptom Manage pii: S0885-3924 (20) 30183-4.  Back to cited text no. 46
Mayor S. COVID-19: Impact on cancer workforce and delivery of care. Lancet Oncol 2020;21:633.  Back to cited text no. 47
Shamieh O, Richardson K, Abdel-Razeq H, Harding R, Sullivan R, Mansour A. The role and response of palliative care and hospice services in epidemics and pandemics: A rapid review to inform practice during the COVID-19 pandemic. J Pain Symptom Manage 2020. (In press) doi:10.1016/j.jpainsymman.2020.03.029.  Back to cited text no. 48
Laventhal N, Basak R, Dell ML, Diekema D, Elster N, Geis G, et al. The ethics of creating a resource allocation strategy during the COVID-19 pandemic. Pediatrics. 2020 (In press) doi:10.1542/peds.2020-1243.  Back to cited text no. 49
Truog RD, Mitchell C, Daley GQ. The toughest triage – Allocating ventilators in a pandemic. N Engl J Med 2020;382:1973-5. [doi: 10.1056/NEJMp2005689].  Back to cited text no. 50
Shamieh O, Richardson K, Abdel-Razeq H, Harding R, Sullivan R, Mansour A. COVID-19 – Impact on DNR orders in the largest cancer center in Jordan. J Pain Symptom Manage 2020. doi:10.1016/j.jpainsymman.2020.04.023.  Back to cited text no. 51
Wu Y, Wang J, Luo C, Hu S, Lin X, Anderson AE, et al. A comparison of burnout frequency among oncologyphysicians and nurses working on the frontline and usualwards during the COVID-19 Epidemic in Wuhan, China. J Pain Symptom Manage. 2020. (In press) doi:10.1016/j.jpainsymman.2020.04.008.  Back to cited text no. 52
Selman LE, Chao D, Sowden R, Marshall S, Chamberlain C, Koffman J. Bereavement support on the frontline of COVID-19: Recommendations for hospital clinicians. J Pain Symptom Manage 2020. pii: S0885-3924 (20) 30244-X.  Back to cited text no. 53
Downar J, Seccareccia D; Associated Medical Services Inc.; Educational Fellows in Care at the End of Life. Palliating a pandemic: “All patients must be cared for”. J Pain Symptom Manage 2010;39:291-5.  Back to cited text no. 54
Levy MH, Back A, Benedetti C, Billings J, Block S, Boston B, et al. Palliative care. J Natl Comprehensive Cancer Network 2009;7:436-73. Available from: [Last retrieved on 2020 May 03].  Back to cited text no. 55
World Health Organization. Cancer Pain Relief with a Guide to Opioid Availability. 2nd ed.. Geneva, Switzerland: World Health Organization; 1996. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 56
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection. Lancet Respirat Med 2020;8:e21.  Back to cited text no. 57
Amici C, Di Caro A, Ciucci A, Chiappa L, Castilletti C, Martella V, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antiviral Ther 2006;11:1021-30.  Back to cited text no. 58
Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52:715-20.  Back to cited text no. 59
Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004;136:95-103.  Back to cited text no. 60
Wong SS, Yuen KY. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother 2008;62:437-41.  Back to cited text no. 61
Zhang X, Alekseev K, Jung K, Vlasova A, Hadya N, Saif LJ. Cytokine responses in porcine respiratory coronavirus-infected pigs treated with corticosteroids as a model for severe acute respiratory syndrome. J Virol 2008;82:4420-8.  Back to cited text no. 62
Beth R, Charlotte M, Anne R, Mieke VH. COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting? E Cancer 2020;14:1023.  Back to cited text no. 63
Donovan EK, Sienna J, Mitera G, Kumar-Tyagi N, Parpia S, Swaminath A. Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis. Radiother Oncol 2019;134:55-66.  Back to cited text no. 64
Thureau S, Faivre JC, Assaker R, Biver E, Confavreux CB, Debiais F, et al. Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper. J Bone Oncol. 2020 (In press) [published online on 2020 Apr 13] doi:10.1016/j.jbo.2020.100291.  Back to cited text no. 65
Yerramilli D, Xu AJ, Gillespie EF, Shepherd AF, Beal K, Gomez D, et al. Palliative Radiotherapy for oncologic emergencies in the setting of COVID-19: Approaches to Balancing Risks and Benefits. Adv Radiat Oncol 2020 (In press) doi: 10.1016/j.adro. 2020.04.001.  Back to cited text no. 66
Narayanan G, Pezeshkmehr A, Venkat S, Guerrero G, Barbery K. Safety and efficacy of the PleurX catheter for the treatment of malignant ascites. J Palliat Med 2014;17:906-12.  Back to cited text no. 67
Thornton RH, Miller Z, Covey AM, Brody L. Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis. J Vascular Interv Radiol 2010;21:696-700.  Back to cited text no. 68
Weinkove R, McQuilten ZK, Adler J, Agar M, Blyth E, Cheng A, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust 2020; 212:481-9.  Back to cited text no. 69
Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Cochrane Database Syst Rev 2016;2:CD009624.  Back to cited text no. 70
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Adv 2019;3:1197-210.  Back to cited text no. 71
World Health Organization. Rational use of Personal Protective Equipment for Coronavirus Disease (COVID-19) and Considerations During Severe Shortages. Interim Guidance; 6 April, 2020. Available from: [Last accessed on 2020 Apr 20].  Back to cited text no. 72
World Health Organization. Advice on the Use of Masks in the Context of COVID-19. Interim Guidance; 6 April, 2020. Available from: -care-and-in-healthcare-settings-in-the-context- of-the-novel-coronavirus-(2019-ncov)-outbreak. [Last accessed on 2020 Apr 20].  Back to cited text no. 73
Curigliano G, Cardoso MJ, Poortmans P, Gentilini O, Pravettoni G, Mazzocco K, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast 2020;52:8-16.  Back to cited text no. 74
ESMO Guidelines. Cancer Patient Management during the COVID-19 Pandemic. Palliative Care Prioritisation during the Covid-19 Crisis. Available from: [Last accessed 2020 May 01].  Back to cited text no. 75
Baik D, Russell D, Jordan L, Dooley F, Bowles KH, Masterson Creber RM. Using the palliative performance scale to estimate survival for patients at the end of life: A systematic review of the literature. J Palliat Med 2018;21:1651-61.  Back to cited text no. 76
Maltoni M, Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1999;17:240-7.  Back to cited text no. 77
Namendys-Silva SA, Texcocano-Becerra J, Herrera-Gómez A. Application of the Sequential Organ Failure Assessment (SOFA) score to patients with cancer admitted to the intensive care unit. Am J Hosp Palliat Care 2009;26:341-6.  Back to cited text no. 78
Guest T, Tantam G, Donlin N, Tantam K, McMillan H, Tillyard A. An observational cohort study of triage for critical care provision during pandemic influenza: 'Clipboard physicians' or 'evidenced based medicine'? Anaesthesia 2009;64:1199-206.  Back to cited text no. 79
Pahuja M, Wojcikewych D. Systems barriers to assessment and treatment of COVID-19 positive patients at the end of life. J Palliat Med. 2020;10.1089/jpm.2020.0190. (In press) doi:10.1089/jpm.2020.0190.  Back to cited text no. 80
Nipp RD, El-Jawahri A, Ruddy M, Fuh C, Temel B, D'Arpino SM, et al. Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer. Ann Oncol 2019;30:274-80.  Back to cited text no. 81
Tieman JJ, Swetenham K, Morgan DD, To TH, Currow DC. Using telehealth to support end of life care in the community: A feasibility study. BMC Palliat Care 2016;15:94.  Back to cited text no. 82
Porzio G, Cortellini A, Bruera E, Verna L, Ravoni G, Peris F, et al. Home Care for cancer patients during COVID-19 pandemic: The “double triage” protocol. J Pain Symptom Manage. 2020 (In press) doi:10.1016/j.jpainsymman.2020.03.021.  Back to cited text no. 83
Cortellini A, Porzio G, Masel EK, Berghoff AS, Knotzer B, Parisi A, et al. The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study. Palliat Support Care 2019;17:82-6.  Back to cited text no. 84
Cortellini A, Porzio G, Cofini V, Necozione S, Parisi A, Peris F, et al. The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings. Palliat Support Care 2020;18:33-8.  Back to cited text no. 85
Bone AE, Gao W, Gomes B. Factors associated with transition from community settings to hospital as place of death for adults aged 75 and older: A population-based mortality follow-back survey. J Am Geriatr Soc 2016;64:2210-7.  Back to cited text no. 86
Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 2018;38:540-5.  Back to cited text no. 87
Sabesan S, Simcox K, Marr I. Medical oncology clinics through videoconferencing: An acceptable telehealth model for rural patients and health workers. Intern Med J 2012;42:780-5.  Back to cited text no. 88
Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 Pandemic: A call to action. JMIR Public Health Surveillance 2020;6:e18810.  Back to cited text no. 89
Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med 2020;382:1679-81. [doi: 10.1056/NEJMp2003539].  Back to cited text no. 90
Adams C. Goals of care in a pandemic: Our experience and recommendations. J Pain Symptom Manage. 2020. (In press) doi:10.1016/j.jpainsymman.2020.03.021.  Back to cited text no. 91
Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: Between threats and opportunities. Future Oncol 2020;16:1225-7. doi:10.2217/fon-2020-0324.  Back to cited text no. 92
Calton B, Abedini N, Fratkin M. Telemedicine in the time of coronavirus. J Pain Symptom Manage. 2020 (In press). doi:10.1016/j.jpainsymman.2020.03.021.  Back to cited text no. 93
Audrey H. Teleconsultation and COVID-19: who can practice remotely and how?. Ministère des Solidarités et de la Santé, (2020). Avilable from: [Last accessed on 2020 Jun 17].  Back to cited text no. 94
Janssen A, Brunner M, Keep M, Hines M, Nagarajan SV, Kielly-Carroll C, et al. Interdisciplinary ehealth practice in cancer care: A review of the literature. Int J Environ Res Public Health 2017;14:1289.  Back to cited text no. 95
Humphreys J, Schoenherr L, Elia G, Saks NT, Brown C, Barbour S, et al. Rapid Implementation of inpatient telepalliative medicine consultations during COVID-19 pandemic. J Pain Symptom Manage. 2020 (In press) doi:10.1016/j.jpainsymman.2020.04.001.  Back to cited text no. 96


  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]


Print this article  Email this article
Online since 1st October '05
Published by Wolters Kluwer - Medknow